INTRODUCTION
The drug "Panchakavvyam" reported to be an anticarcinogenic agent in yajur Vedhika 24 has been made to reverse cachexia and to selectively deprive the tumour cells for catabolishing the nutrients, and the structural components of the host cells which are necessary for the normophysiology of tumour locus, by feeding a ketogenic regimen.
If tumour bearing mice are provided with an exogenous supply of fatty acids, ketonemia is observed suggesting no impairment of the liver in its ability to synthesize ketone bodies 3, 13 .
The cachectic syndrome is characterized by depletion of the host muscle and adipose mass and a reduction in insulin secretion 7, 21 accompanied by a lower serum glucose level and an elevation in serum unesterified fatty acid levels 1 .
A low carbohydrate ketogenic diet might be expected to prevent host catabolism during cachexia and, in addition, reduces the rate of growth of tumours which depend on glucose for energy 22 .
Normally, plasma lipid levels are governed by tissue metabolism and permeability of cell membranes to lipid constituents. While lipid changes with dietary fat modifications have been restricted to plasma, liver, aortic smooth muscles cells and fibroblasts in animals 6 .
Thus panchakavvyam is capable of reversing the adverse effects of cachexia, which results in prolonging the survival time of the tumour-bearing rats. After 40 days of drug administration, daily the animals were sacrified and the following parameters were estimated in serum of control and experimental animals.
Protein was estimated according to the method of Lowry et al 12 cholesterol ester synthetase 9 , cholesterol ester hydrolase 10 , total cholesterol and ester cholesterol 16 , triglyceride 19 , phospholipid 20 free fatty acid 8 were estimated.
For all the statistical evaluations, "student's T test" was used, to detect significant changes associated with various groups.
Results and Discussions
Depletion of the host muscle protein, glycogen and lipids accompanied by a lower serum glucose level and an elevation in free cholesterol, and a decrease in neutral fat have been reported 1 . Hence, the loss of major nutrients, particularly, excessive catabolism of lipids, leads to cachexia and the chronic and acute cachectic conditions finally leads to death in rats 21 . Table 1 shows the individuals lipid levels in both control and experimental animals. Individual lipids, namely total cholesterol, ester cholesterol, free cholesterol, triglycerides, phospholipids and free fatty acids are studied in control and experimental rats.
It is observed from table 1, a significant increase in free cholesterol and phospholipids (p < 0.001); total cholesterol (p<0.01) significance; and free fatty acid (p<0.05) in group II animals. Hyperlipemia associated with cancer has been attributed to the mobilization of fat from the stores, both to meet the increased energy demands of the tumour bearing host and to supply unsaturated fatty acids for the maintenance of high concentration of phospholipids with in the tumour.
The lipemia subsides terminally and it is found that the fat stores are empty 2 to meet increased caloric requirements of the host, during acute cancer condition.
In contrast, the table 1 shows a decrease ester cholesterol (p < 0.001) and triglycerides (p < 0.05) in Group II animals when compared with Group I, and significant increase in ester cholesterol (p < 0.001), triglyceride in Group III when compared with Group II.
Panchakavvyam treated Group III rats, also show a decrease in the levels of total cholesterol (p < 0.05), ester cholesterol (p < 0.001), free cholesterol (p < 0.001), phospholipids and free fatty acids in serum. Table 2 shows the change in enzyme levels, namely, cholesterol ester synthetase and cholesterol ester hydrolase in serum of both control and experimental rats. In Group II animals, a significant increase in cholesterol ester synthetase (p < 0.001) and a decrease in cholesterol ester hydrolase (p < 0.01) is observed.
In contrast, Panchakavvyam administered Group III animals, show decrease in cholesterol ester synthetase (p < 0.01) and gradual increase in Cholesterol ester hydrolase (p < 0.005).
In group II animals, CEH/CES ratio is markedly decreased when compared with Group I and Group III animals.
Elevation of plasma cholesterol mainly free cholesterol was observed in tumour induced rats. The high level of free cholesterol might have been due to low activity of lecithin cholesterol acyl transferase (LCAT) which is responsible for generating a major portions of cholesterol esters. The decreased ester cholesterol and increased free cholesterol levels in plasma indirectly aids the rapid multiplication of already proliferating cells 18 .
In rat models, cholesterol levels are increased in cancer cells due to enhanced cholesterogenesis 17 . In the metabolic turnover via hexose monophosphate shunt pathway is also increased to provide NADPH (Reduced nicotinamideadenine dinucleotide phosphate) for cholesterol synthesis and ribolse phosphate synthesis for augmented nucleic acid synthesis.
The elevated level of free fatty acids could have contributed to the elevated triglyceride level in liver and kidney. The elevated plasma triglyceride level observed in tumour induced rats might have been partially due to lipoprotein lipase 15 . Stimulation of lipid peroxidation has been reported to influence lipid metabolism in the biological system which can cause tumours 4 .
The synthesized cholesterol is rapidly esterified to ester cholesterol by cholesterol ester synthetase (CES), thus reducing the free cholesterol level which will otherwise inhibit the rate of limiting enzyme hydroxyl methyl glutaryl coenzyme A (HMG CoA) reductase in cancer cells 5 . CES is increased and CEH is decreased substantially in tumour induced experimental animals when compared with controls.
The CEH/CES ratio is decreased. Elevation in plasma cholesterol is mediated through increased turnover and is influenced by relative balance between CEH/CES in the peripheral cells.
Increased activity of CES inside proliferating fibrosarcoma cells, may cause increased cholesterogenesis and rapid multiplication of already proliferating cells. The above hypothesis is supported by similar observation of Rao et al 18 in acinar cell carcinoma of pancreas.
Panchakavvyam is comprised of chiefly lipid and protein and low carbohydrates. Since the drug contains high far, it supplies the fat required by the tumour -bearing animals thus preventing them from going in for cachectic syndrome and prolonging the life span.
Thus, large quantities of exogenous substrates are associated with an increase metabolic rate and stimulation of tumour growth. By increasing the lipid contribution to the nutritional regimen, it is possible to prevent the host weight loss while reducing tumour size 23 .
Accordingly, the drug, panchakavvyam, which fulfills the specific requirement to suppress the tumour development nutritionally, can be considered to be having anticarcinogenic properties.
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